Close Menu

NEW YORK — SphingoTec said on Tuesday that it has signed commercialization agreements with Sysmex and its subsidiary Hitado for its Nexus IB10 point-of-care immunoassay platform in Switzerland and Germany, respectively.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.